Blood disorders affect millions of people worldwide, yet their potential to develop into blood cancers often goes unrecognized. Medical experts emphasize that understanding this connection plays a ...
“The Transfusion Medicine Service in the Department of Pathology performs therapeutic apheresis on patients who have an illness associated with an abnormal cellular or plasma-based blood component,” ...
Some health issues are easy to spot and feel on the outside, but they become complicated when they affect the inside, including your blood. A new survey by LloydsPharmacy Online Doctor reveals that 75 ...
Reblozyl (luspatercept-aamt) is a prescription drug used to treat anemia in adults with certain blood disorders. Reblozyl can cause side effects that range from mild to serious. These include ...
The Global Action Network for Sickle Cell & other Inherited Blood Disorders (GANSID), together with its partners and supporters, is preparing to celebrate the inaugural World Inherited Blood Disorders ...
With phase 3 trial win, PharmaEssentia plots label expansion for rare blood cancer treatment Besremi
PharmaEssentia is looking to expand the reach of its FDA-approved rare blood cancer treatment Besremi to another rare blood disorder after reviewing encouraging results from a phase 3 study. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results